Alaris Royalty Corp. (AD) To Go Ex-Dividend on October 30th

Share on StockTwits

Alaris Royalty Corp. (TSE:AD) announced a monthly dividend on Wednesday, October 30th, TickerTech reports. Shareholders of record on Friday, November 15th will be given a dividend of 0.1375 per share on Friday, November 15th. This represents a $1.65 annualized dividend and a yield of 8.44%. The ex-dividend date of this dividend is Wednesday, October 30th.

AD stock opened at C$19.55 on Monday. The company has a quick ratio of 1.90, a current ratio of 4.63 and a debt-to-equity ratio of 44.12. Alaris Royalty has a 52-week low of C$16.27 and a 52-week high of C$21.43. The stock’s 50 day moving average is C$19.57 and its two-hundred day moving average is C$19.39. The company has a market capitalization of $715.81 million and a PE ratio of 10.29.

In other news, Senior Officer Amanda Mai Frazer sold 1,900 shares of Alaris Royalty stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of C$19.75, for a total value of C$37,525.00. Following the completion of the transaction, the insider now owns 12,213 shares in the company, valued at approximately C$241,206.75. Also, Director John Frederick Ripley bought 50,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The stock was purchased at an average price of C$19.83 per share, with a total value of C$991,740.00. Following the transaction, the director now owns 62,500 shares in the company, valued at approximately C$1,239,675. In the last quarter, insiders sold 5,700 shares of company stock valued at $112,316.

Several equities research analysts have issued reports on the company. National Bank Financial lifted their price objective on Alaris Royalty from C$18.00 to C$19.00 and gave the stock a “sector perform” rating in a report on Thursday, July 25th. Raymond James lifted their price objective on Alaris Royalty from C$19.50 to C$20.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. CIBC upgraded Alaris Royalty from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from C$22.00 to C$25.00 in a research report on Friday, July 12th. Finally, Royal Bank of Canada lifted their target price on Alaris Royalty from C$22.00 to C$23.00 and gave the stock an “outperform” rating in a research report on Friday, July 26th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Alaris Royalty currently has an average rating of “Buy” and a consensus price target of C$21.92.

About Alaris Royalty

Alaris Royalty Corp. is a private equity firm specializing in management buyouts, growth capital, lower & middle market, later stage, industry consolidation, growth capital, and mature investments. The firm does not invest in turnarounds and start-ups. It prefers to invest in the companies based in all industries except for those with a declining asset base, such as oil and gas resource companies, or any industry that carry the risk of obsolescence such as high tech and focuses on business services, professional services, information services, healthcare services, distribution & logistics, industrials, consumer products.

Featured Article: Gap Up Stocks

Dividend History for Alaris Royalty (TSE:AD)

Receive News & Ratings for Alaris Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alaris Royalty and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks Investment Research Upgrades Grafton Group  to Hold
Zacks Investment Research Upgrades Grafton Group to Hold
Zacks Investment Research Upgrades SEIKO EPSON COR/ADR  to Hold
Zacks Investment Research Upgrades SEIKO EPSON COR/ADR to Hold
Zacks Investment Research Downgrades Metro Bank  to Sell
Zacks Investment Research Downgrades Metro Bank to Sell
Aviva  Rating Reiterated by UBS Group
Aviva Rating Reiterated by UBS Group
Short Interest in China Pharma Holdings, Inc.  Declines By 93.2%
Short Interest in China Pharma Holdings, Inc. Declines By 93.2%
Short Interest in Income Opportunity Realty Investors Inc  Decreases By 71.4%
Short Interest in Income Opportunity Realty Investors Inc Decreases By 71.4%


© 2006-2019 Ticker Report